Clinical Trial: Study to Assess Drug Levels, Immune Response, Safety and Tolerability of BMS-986446 in Healthy Chinese Participants.

U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07852962) titled 'Study to Assess Drug Levels, Immune Response, Safety and Tolerability of BMS-986446 in Healthy Chinese Participants.' on Sept. 24.

Brief Summary: The purpose of this study is to assess the drug levels, immune response, safety and tolerability of BMS-986446 in healthy Chinese participants.

Study Start Date: Feb. 10, 2027

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: BMS-986446

Specified dose on specified days

OTHER: Placebo

Specified dose on specified days

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Bristol-Myers Squibb

Published by HT Digital Content Services with permission from Health ...